Acute leukemia with a very high leukocyte count: Confronting a medical emergency

Cleveland Clinic Journal of Medicine

Volumn 71, Issue 8, 2004, Pages 633-637

  Majhail, Navneet S ^a   Lichtin, Alan E ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ACUTE LEUKEMIA; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; EMERGENCY; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTOSIS; LEUKOSTASIS; PATIENT REFERRAL; RESPIRATORY FAILURE; REVIEW; SYMPTOM;

EID: 4444263846     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.71.8.633     Document Type: Review

References (28)

1. Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M. Leukocytoreduction for acute leukemia. Ther Apher 2002; 6:15-23.
2. Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation, and management. Leuk Lymphoma 2000; 39:1-18.
3. Hoelzer D, Thiel E, Loffler H, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71:123-131.
4. Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 1987; 5:1364-1372.
5. van Buchem MA, te Velde J, Willemze R, Spaander PJ. Leucostasis, an underestimated cause of death in leukaemia. Blut 1988; 56:39-44.
6. McKee LC, Collins RD. Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia. Medicine (Baltimore) 1974; 53:463-478.
7. Soares FA, Landell GA, Cardoso MC. Pulmonary leukostasis without hyperleukocytosis: a clinicopathologic study of 16 cases. Am J Hematol 1992; 40:28-32.
8. Lightman MA. Rheology of leukocytes, leukocyte suspensions, and blood in leukemia. Possible relationship to clinical manifestations. J Clin Invest 1973; 52:350-358.
9. van Buchem MA, Hogendoorn PC, Bruijn JA, Kluin PM. Endothelial activation antigens in pulmonary leukostasis in leukemia. Acta Haematol 1993; 90:29-33.
10. Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Spertini O. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood 2001; 97:2121-2129.
11. De Waele M, Renmans W, Jochmans K, et al. Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts. Eur J Haematol 1999; 63:192-201.
12. Cavenagh JD, Gordon-Smith EC, Gibson FM, Gordon MY. Acute myeloid leukaemia blast cells bind to human endothelium in vitro utilizing E-selectin and vascular cell adhesion molecule-1 (VCAM-1). Br J Haematol 1993; 85:285-291.
13. van Buchem MA, Wondergem JH, Kool LJ, et al. Pulmonary leukostasis: radiologic-pathologic study. Radiology 1987; 165:739-741.
14. Fox MJ, Brody JS, Weintraub LR. Leukocyte larceny: a cause of spurious hypoxemia. Am J Med 1979; 67:742-746.
15. Loke J, Duffy TP. Normal arterial oxygen saturation with the ear oximeter in patients with leukemia and leukocytosis. Cancer 1984; 53:1767-1769.
16. Armitage JO, Goeken JA, Feagler JR. Spurious elevation of the platelet count in acute leukemia. JAMA 1978; 239:433-434.
17. Hammerstrom J. Spurious platelet counts in acute leukaemia with DIC due to cell fragmentation. Clin Lab Haematol 1992; 14:239-243.
18. Flasshove M, Schuette J, Sauerwein W, Hoeffken K, Seeber S. Pulmonary and cerebral irradiation for hyperleukocytosis in acute myelomonocytic leukemia. Leukemia 1994; 8:1792.
19. Grund FM, Armitage JO, Burns P. Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia. Arch Intern Med 1977; 137:1246-1247.
20. Berg J, Vincent PC, Gunz FW. Extreme leucocytosis and prognosis of newly diagnosed patients with acute non-lymphocytic leukaemia. Med J Aust 1979; 1:480-482.
21. Gilchrist GS, Fountain KS, Dearth JC, Smithson WA, Burgert EO. Cranial irradiation in the management of extreme leukemic leukocytosis complicating childhood acute lymphocytic leukemia. J Pediatr 1981; 98:257-259.
22. Butler RW, Hill JM, Steinherz PG, Meyers PA, Finlay JL. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol 1994; 12:2621-2629.
23. Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, McCarthy LJ. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol 1997; 98:433-436.
24. Giles FJ, Shen Y, Kantarjian HM, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma 2001; 42:67-73.
25. Thiebaut A, Thomas X, Belhabri A, Anglaret B, Archimbaud E. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis. Ann Hematol 2000; 79:501-506.
26. Basade M, Dhar AK, Kulkarni SS, et al. Rapid cytoreduction in childhood leukemic hyperleukocytosis by conservative therapy. Med Pediatr Oncol 1995; 25:204-207.
27. Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol 1985; 3:1590-1595.
28. Eguiguren JM, Schell MJ, Crist WM, Kunkel K, Rivera GK. Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood 1992; 79:871-875.